Neubase Therapeutics (NBSE) Investor Presentation - Slideshow

NEUBASE THERAPEUTICS, INC. 1 Corporate Overview | September 2022 Drugging the Genome™ With Precision Genetic Medicines Safe Harbor Statement Certain statements contained in this presentation regarding matters that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include statements regarding management's intentions, plans, beliefs, ex ...